We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

75 hedge funds and large institutions have $84.3M invested in Cascadian Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $94K | Put options by funds: $55K

18% more capital invested

Capital invested by funds: $71.2M → $84.3M (+$13.1M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 80 → 75 (-5)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
17
Reduced
21
Closed
22
Calls
$94K
Puts
$55K
Net Calls
+$39K
Net Calls Change
-$446K

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$28.3M
2
NMC
NEA Management Company
Maryland
+$12.2M
3
ACA
Avoro Capital Advisors
New York
+$1.9M
4
EAM
EverPoint Asset Management
Connecticut
+$1.7M
5
Millennium Management
Millennium Management
New York
+$721K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.48M
2
State Street
State Street
Massachusetts
-$1.77M
3
GCM
Gruss Capital Management
New York
-$1.41M
4
Northern Trust
Northern Trust
Illinois
-$1.01M
5
BIT
BlackRock Institutional Trust
California
-$902K
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$23.6M +$28.3M +4,166,667 New
BI
2
BVF Inc
California
$17.7M – – –
NMC
3
NEA Management Company
Maryland
$10.1M +$12.2M +1,791,667 New
Franklin Resources
4
Franklin Resources
California
$6.51M – – –
ACA
5
Avoro Capital Advisors
New York
$5.42M +$1.9M +279,275 +41%
PA
6
Perceptive Advisors
New York
$3.22M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$3.14M -$274K -40,331 -7%
BIT
8
BlackRock Institutional Trust
California
$1.72M -$902K -132,805 -30%
EAM
9
EverPoint Asset Management
Connecticut
$1.42M +$1.7M +250,000 New
BFA
10
BlackRock Fund Advisors
California
$1.39M -$2.48M -364,736 -60%
FO
11
FT Options
Illinois
$1.05M +$115K +17,009 +10%
Deutsche Bank
12
Deutsche Bank
Germany
$925K +$469K +69,011 +73%
AFM
13
Anson Funds Management
Texas
$847K +$241K +35,500 +31%
SM
14
Sabby Management
Florida
$815K +$142K +20,900 +17%
Millennium Management
15
Millennium Management
New York
$601K +$721K +106,237 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$502K -$110K -16,220 -15%
First Eagle Investment Management
17
First Eagle Investment Management
New York
$377K +$113K +16,667 +33%
CS
18
Credit Suisse
Switzerland
$345K +$387K +57,034 +1,395%
PP
19
Paloma Partners
Connecticut
$337K +$404K +59,558 New
CAM
20
ClariVest Asset Management
California
$294K +$79.2K +11,661 +29%
PCM
21
Perkins Capital Management
Minnesota
$290K -$4.7K -692 -1%
Goldman Sachs
22
Goldman Sachs
New York
$287K +$283K +41,622 +457%
LCM
23
Laurion Capital Management
New York
$258K +$309K +45,517 New
SKK
24
Shepherd Kaplan Krochuk
Massachusetts
$247K +$296K +43,641 New
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$246K -$161K -23,750 -35%
1
2 3 4

CASC Hedge Fund Activity: Q2 2016 in Review

75 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q2 2016, worth a combined $84.3M — up 18% from $71.2M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CASC and 18 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 17 added.

The largest buyer was Baupost Group, opening a new position worth an estimated $28.3M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.48M.

  • 75 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q2 2016, down from 80 in Q1 2016.
  • Funds reported $84.3M of Cascadian Therapeutics, Inc. stock for Q2 2016, up 18% quarter-over-quarter.
  • 18 funds opened new Cascadian Therapeutics, Inc. positions in Q2 2016 and 22 closed out, a net change of -4 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q2 2016 was Baupost Group, an estimated $28.3M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q2 2016 was BlackRock Fund Advisors, an estimated $2.48M sold.

Based on aggregated 13F filings for Q2 2016.